TherapeuticsMD (TXMD) Research & Development (2011 - 2022)
TherapeuticsMD (TXMD) reported Research & Development of $1.11 million for Q3 2022, down 30.7% from $1.61 million a year earlier and down 29.6% from the prior quarter.
Powered by 
Analysis
TherapeuticsMD (TXMD) Research & Development (2011 - 2022) Analysis & Trends
Over the twelve months ended Sep 30, 2022, TherapeuticsMD's Research & Development came in at $5.51 million, down 31.6% year-over-year; for FY2021, it was $7.09 million, down 32.1% from FY2020.
- Research & Development has declined for six consecutive years, with a five-year compound annual growth rate of -33.4% (FY2016 to FY2021).
- By year, Research & Development came in at $10.43 million in FY2020 (-47.3%), $19.79 million in FY2019 (-27.5%), $27.3 million in FY2018 (-19.4%) and $33.85 million in FY2017 (-37.2%).
- The Q3 2022 figure ranks as the lowest quarterly Research & Development since Q2 2012.
- Year over year, Research & Development has now declined in each of the last 16 quarters, with an average decline of 31.9% over the last eight quarters.
- The high point for year-over-year Research & Development in five years was Q4 2017 (growth of 6.1%); the low point was Q3 2020 (a decline of 50.3%).
- Per Business Quant data, the three quarters before Q3 2022 came in at $1.58 million (Q2 2022), $1.4 million (Q1 2022) and $1.42 million (Q4 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 2.81 Bn |
| 10 | TherapeuticsMD | 21.67 Mn | 21.67 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 1.11 Mn |
| Jun 30, 2022 | 1.58 Mn |
| Mar 31, 2022 | 1.40 Mn |
| Dec 31, 2021 | 1.42 Mn |
| Sep 30, 2021 | 1.61 Mn |
| Jun 30, 2021 | 2.01 Mn |
| Mar 31, 2021 | 2.05 Mn |
| Dec 31, 2020 | 2.39 Mn |
| Sep 30, 2020 | 2.03 Mn |
| Jun 30, 2020 | 2.74 Mn |
| Mar 31, 2020 | 3.27 Mn |
| Dec 31, 2019 | 4.43 Mn |
| Sep 30, 2019 | 4.08 Mn |
| Jun 30, 2019 | 4.96 Mn |
| Mar 31, 2019 | 6.32 Mn |
| Dec 31, 2018 | 6.75 Mn |
| Sep 30, 2018 | 6.71 Mn |
| Jun 30, 2018 | 6.80 Mn |
| Mar 31, 2018 | 7.04 Mn |
| Dec 31, 2017 | 10.97 Mn |
API Access
TherapeuticsMD Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=TXMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "TXMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=TXMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();